A Double-blind, Placebo-Controlled Dose-Response Comparison of Intramuscular Olanzapine and Haloperidol in the Treatment of Acute Agitation in Schizophrenia - Concepedia

Concepedia

Publication | Closed Access

A Double-blind, Placebo-Controlled Dose-Response Comparison of Intramuscular Olanzapine and Haloperidol in the Treatment of Acute Agitation in Schizophrenia

285

Citations

39

References

2002

Year

Alan Breier, Karena Meehan, Martin Birkett, S.R. David, Iris Ferchland, Virginia K. Sutton, Cindy C. Taylor, R. Palmer, Martín Dossenbach, Geri Kiesler,

Archives of General Psychiatry

Abstract

Intramuscular olanzapine at a dose of 2.5 to 10.0 mg per injection exhibits a dose-response relationship in the rapid treatment of acute agitation in patients with schizophrenia and demonstrates a favorable safety profile.

References

	Year	Citations

Page 1